Dr. Hans-Lothar ArthDr. Jennifer BaltesDr. Dianne SnowdenBoo Geun KIM, Ph.D.Oliviana Călin, Ph.D.Dipl.-Chem. Senada DuricTianna Dauner, J.D.M.Sc. Limin Siebert-SuDipl.-Ing. Kirstin Bettin


Imatinib (Gleevec)

Boo Geun KIM, Ph.D.

Dr. Boo Geun Kim is a chemist. He obtained his B.S. and M.S. degree of industrial chemistry at the Hanyang University, Seoul, Korea. He visited chemistry diploma course at TU Berlin and obtained his doctorate in chemistry at Potsdam University.

During his doctorate his research focused on organometal-induced stereoselective radical reaction and [3+2] cycloaddition of nitronates and their application for synthesis of ulosonic acids and carbohydrate C-analogues. 

He worked as a postdoc in a medicinal chemistry group at Leibniz-institute of molecular pharmacology (FMP) in Berlin. His research topic was development of new phosphatase inhibitor for treatment of acute myeloid leukemia. He has acquired experience in high-throughput screening (HTS), hit-to-lead optimization, validation by in vitro assays, high-throughput library synthesis by synthetic robot,  synthetic automation and compound management.

His scientific expertise focuses on organic chemistry, medicinal chemistry, pharmacy, organometallic chemistry and polymer chemistry.

He speaks German, English and Korean fluently and has good knowledge of Japanese.

Dr. Kim’s work focuses on international and European application, expert opinions and advising of clients in Asia.